Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4

Cited by papers we hold 2

• ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation · 2021
  No notice
• B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.